The drug discovery revolution is real but radically overstated, the health chatbots are a documented hazard, and the diseases that matter most remain stubbornly unsolved. At Novartis, sometime in late 2025, a team of researchers working on Huntington’s disease used generative AI to computationally design 15 million potential compounds for a type of molecule called […]<br /> This story continues at The Next Web [...]
With "Epicure," London-based startup Kaikaku.AI presents three AI models that are the first to clearly separate whether an ingredient fits a recipe or is chemically related. Trained on 4.14 [...]
Day three of Amazon Prime Day is here, so Prime members can still take advantage of the long-awaited discounts across Amazon’s site. The online retailer has hosted its main, annual shopping event in [...]